Variable

Total (N = 58)

Age at diagnosis (years)—mean ± SD

(minimum - maximum)

41.85 ± 6.38

(28.00 - 52.00)

Age at diagnosis—n (%)

29 - 35 years

36 - 40 years

41 - 45 years

46 - 50 years

13 (22.4)

11 (19.0)

18 (31.0)

16 (27.6)

Tumor size—n (%)

T1

T2

T3

T4

INO

24 (41.4)

22 (37.9)

7 (12.1)

3 (5.2)

2 (3,4)

Lymph node involvement—n (%)

23 (39.7)

Hormone receptors—n (%)

37 (63.8)

HER2 hyperexpressed—n (%)

6 (10.3)

Type of surgery—n (%)

Sectorectomy

Mastectomy without reconstruction

Mastectomy with reconstruction

INO

23 (39.7)

3 (5.2)

30 (51.7)

2 (3.4)

Chemotherapy—n (%)

Geral

Adjuvant chemotherapy

Neoadjuvant chemotherapy

48 (82.8)

24 (41.4)

25 (43.1)

Radiotherapy—n (%)

39 (67.2)

Hormone therapy—n (%)

Tamoxifen

Aromatase inhibitor

33 (56.9)

5 (8.6)